p48/64 MW HPC Flow Modulation Device

· phenox Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for p48/64 MW HPC Flow Modulation Device, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms [NA]